• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

A STUDY ON EFFECT OF PSYCHOSOCIAL ISSUES ON TREATMENT INTERRUPTIONS AND QUALITY OF LIFE ASSESSMENT AMONG CANCER PATIENTS AND THEIR ATTENDENTS IN A TERTIARY CANCER CARE INSTITUTE

    Dr Radhika Parimkayala ,Dr Kanugula Sravanthi, Dr Malladi Ramakrishna

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 5982-6000

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Routine screening for distress is internationally recommended as a standard of
care among cancer patients. This study was conducted to assess the level of stress and
determine the association between quality of life (QOL) with demographic, socio-economic
status, treatment phase, cancer stage.
Aim: To assess the psychosocial issues in treatment interruptions, quality of life in cancer
patients and their attendants.
Materials and methods:Prospective Observational study done inMNJ Institute Of Oncology
and Regional Cancer Centre, Osmania Medical College, Hyderabad from July 2018 to June
2020. Biopsy proven cancer patients of head and neck, cervix and breast visiting OPD. The
target population were interviewed using preselected questionnaires. The EORTC quality of
life questionnaire (QLQ) is an integrated system for assessing the health related quality of life
(QOL) of cancer patients. The core questionnaire, the QLQ – C30, is the product of more
than a decade of collaborative research.
Results: Patients with head & neck, cervical, and breast cancer had a significantly better
quality of life two months following treatment than they did throughout treatment. When
compared to caregivers of breast and cervical cancer patients, caregivers of head and neck
cancer patients had a lower quality of life. In comparison to before therapy, carers' quality of
life was poor towards the completion of treatment. Young and male carers were found to be
more burdened and disruptive. Interruptions in patient treatment were linked to caregivers'
increased strain and disruptiveness.
Conclusion: When compared to patients with cervical and breast cancer, people with head
and neck cancer had a lower quality of life. Interruptions in patient treatment were linked to
caregivers' increased strain and disruptiveness.
Keywords:
    quality of life (QOL) Disruptiveness Burdened
  • PDF (325 K)
  • XML
(2022). A STUDY ON EFFECT OF PSYCHOSOCIAL ISSUES ON TREATMENT INTERRUPTIONS AND QUALITY OF LIFE ASSESSMENT AMONG CANCER PATIENTS AND THEIR ATTENDENTS IN A TERTIARY CANCER CARE INSTITUTE. European Journal of Molecular & Clinical Medicine, 9(3), 5982-6000.
Dr Radhika Parimkayala ,Dr Kanugula Sravanthi, Dr Malladi Ramakrishna. "A STUDY ON EFFECT OF PSYCHOSOCIAL ISSUES ON TREATMENT INTERRUPTIONS AND QUALITY OF LIFE ASSESSMENT AMONG CANCER PATIENTS AND THEIR ATTENDENTS IN A TERTIARY CANCER CARE INSTITUTE". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 5982-6000.
(2022). 'A STUDY ON EFFECT OF PSYCHOSOCIAL ISSUES ON TREATMENT INTERRUPTIONS AND QUALITY OF LIFE ASSESSMENT AMONG CANCER PATIENTS AND THEIR ATTENDENTS IN A TERTIARY CANCER CARE INSTITUTE', European Journal of Molecular & Clinical Medicine, 9(3), pp. 5982-6000.
A STUDY ON EFFECT OF PSYCHOSOCIAL ISSUES ON TREATMENT INTERRUPTIONS AND QUALITY OF LIFE ASSESSMENT AMONG CANCER PATIENTS AND THEIR ATTENDENTS IN A TERTIARY CANCER CARE INSTITUTE. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 5982-6000.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 61
  • PDF Download: 79
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus